Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Current status of liquid biopsies for the detection and management of prostate cancer.

Lu YT, Delijani K, Mecum A, Goldkorn A.

Cancer Manag Res. 2019 Jun 6;11:5271-5291. doi: 10.2147/CMAR.S170380. eCollection 2019. Review.

2.

Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.

Morrison GJ, Goldkorn A.

Curr Oncol Rep. 2018 Mar 23;20(4):35. doi: 10.1007/s11912-018-0683-0. Review.

PMID:
29572775
3.

Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.

Giannopoulou L, Zavridou M, Kasimir-Bauer S, Lianidou ES.

Transl Res. 2019 Mar;205:77-91. doi: 10.1016/j.trsl.2018.10.003. Epub 2018 Oct 12. Review.

PMID:
30391474
4.

Liquid biopsy: ready to guide therapy in advanced prostate cancer?

Hegemann M, Stenzl A, Bedke J, Chi KN, Black PC, Todenhöfer T.

BJU Int. 2016 Dec;118(6):855-863. doi: 10.1111/bju.13586. Epub 2016 Aug 19. Review.

5.

Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.

Nimir M, Ma Y, Jeffreys SA, Opperman T, Young F, Khan T, Ding P, Chua W, Balakrishnar B, Cooper A, De Souza P, Becker TM.

Cells. 2019 Jul 8;8(7). pii: E688. doi: 10.3390/cells8070688.

6.

The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.

Bracht JWP, Mayo-de-Las-Casas C, Berenguer J, Karachaliou N, Rosell R.

Curr Oncol Rep. 2018 Jul 20;20(9):70. doi: 10.1007/s11912-018-0720-z. Review.

PMID:
30030656
7.

Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer.

Hench IB, Hench J, Tolnay M.

Front Med (Lausanne). 2018 Jan 30;5:9. doi: 10.3389/fmed.2018.00009. eCollection 2018. Review.

8.

Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).

Finotti A, Allegretti M, Gasparello J, Giacomini P, Spandidos DA, Spoto G, Gambari R.

Int J Oncol. 2018 Oct;53(4):1395-1434. doi: 10.3892/ijo.2018.4516. Epub 2018 Aug 6. Review.

9.

Research landscape of liquid biopsies in prostate cancer.

Campos-Fernández E, Barcelos LS, de Souza AG, Goulart LR, Alonso-Goulart V.

Am J Cancer Res. 2019 Jul 1;9(7):1309-1328. eCollection 2019. Review.

10.

Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells.

Lin M, Chen JF, Lu YT, Zhang Y, Song J, Hou S, Ke Z, Tseng HR.

Acc Chem Res. 2014 Oct 21;47(10):2941-50. doi: 10.1021/ar5001617. Epub 2014 Aug 11. Review.

11.

Review: Microfluidics technologies for blood-based cancer liquid biopsies.

Sun Y, Haglund TA, Rogers AJ, Ghanim AF, Sethu P.

Anal Chim Acta. 2018 Jul 5;1012:10-29. doi: 10.1016/j.aca.2017.12.050. Epub 2018 Feb 3. Review.

PMID:
29475470
12.

Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.

Zhang X, Ju S, Wang X, Cong H.

Clin Exp Med. 2019 Aug;19(3):271-279. doi: 10.1007/s10238-019-00563-w. Epub 2019 Jun 12. Review.

PMID:
31190187
13.

Liquid Biopsy: General Concepts.

Poulet G, Massias J, Taly V.

Acta Cytol. 2019 May 15:1-7. doi: 10.1159/000499337. [Epub ahead of print] Review.

PMID:
31091522
14.

Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?

Moutinho-Ribeiro P, Macedo G, Melo SA.

Front Endocrinol (Lausanne). 2019 Jan 8;9:779. doi: 10.3389/fendo.2018.00779. eCollection 2018. Review.

15.

Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.

Soekmadji C, Corcoran NM, Oleinikova I, Jovanovic L; Australian Prostate Cancer Collaboration BioResource, Ramm GA, Nelson CC, Jenster G, Russell PJ.

Prostate. 2017 Oct;77(14):1416-1423. doi: 10.1002/pros.23403. Epub 2017 Aug 29. Review.

PMID:
28856701
16.

Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.

Sharp A, Welti JC, Lambros MBK, Dolling D, Rodrigues DN, Pope L, Aversa C, Figueiredo I, Fraser J, Ahmad Z, Lu C, Rescigno P, Kolinsky M, Bertan C, Seed G, Riisnaes R, Miranda S, Crespo M, Pereira R, Ferreira A, Fowler G, Ebbs B, Flohr P, Neeb A, Bianchini D, Petremolo A, Sumanasuriya S, Paschalis A, Mateo J, Tunariu N, Yuan W, Carreira S, Plymate SR, Luo J, de Bono JS.

Eur Urol. 2019 Apr 27. pii: S0302-2838(19)30285-4. doi: 10.1016/j.eururo.2019.04.006. [Epub ahead of print]

17.

Using circulating tumor cells to inform on prostate cancer biology and clinical utility.

Li J, Gregory SG, Garcia-Blanco MA, Armstrong AJ.

Crit Rev Clin Lab Sci. 2015;52(4):191-210. doi: 10.3109/10408363.2015.1023430. Epub 2015 Jun 16. Review.

18.

Liquid biopsies.

Lianidou E, Pantel K.

Genes Chromosomes Cancer. 2019 Apr;58(4):219-232. doi: 10.1002/gcc.22695. Review.

PMID:
30382599
19.

Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons.

Tan CR, Zhou L, El-Deiry WS.

Curr Colorectal Cancer Rep. 2016 Jun;12(3):151-161. Epub 2016 Apr 7.

20.

Clinical utility of emerging liquid biomarkers in advanced prostate cancer.

Vandekerkhove G, Chi KN, Wyatt AW.

Cancer Genet. 2018 Dec;228-229:151-158. doi: 10.1016/j.cancergen.2017.08.003. Epub 2017 Aug 25. Review.

PMID:
28958406

Supplemental Content

Support Center